{
  "name" : "zero.sci-hub.se_5766_ef1cbe9444683f9a6f3dec4118d99ff1_beitollahi2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Graphene Oxide/ZnO Nano Composite for Sensitive and Selective Electrochemical Sensing of Levodopa and Tyrosine Using Modified Graphite Screen Printed Electrode",
    "authors" : [ "Hadi Beitollahi", "Fariba Garkani Nejad" ],
    "emails" : [ "h.beitollahi@yahoo.com" ],
    "sections" : [ {
      "heading" : "1 Introduction",
      "text" : "Parkinson s disease is a chronic neurodegenerative disease that occurs when the substantia nigra of the midbrain dies and fails to generate enough dopamine [1]. This condition causes tremors, muscle stiffness or rigidity, slowness of movement and poor balance [2]. Levodopa, is one of the catecholamine and a kind of the essential precursors for the biosynthesis of dopamine. Levodopa can be principally metabolized by an enzymatic reaction (dopa-descarboxilase) to dopamine compensating for the deficiency of dopamine in the brain [3]. Introduction of levodopa in the 1960s revolutionized the treatment of Parkinson s disease [4]. Dopamine cannot be administered directly because it cannot penetrate the blood brain barrier, but since levodopa is able to cross the blood- brain barrier, it is used to increase dopamine levels [5–7].\nTyrosine is an important amino acid that extensively exists in human body [8, 9]. In the human body, tyrosine is a precursor of several neurotransmitters including levodpa, norepinephrine and epinephrine [10,11] and levodopa is synthesized from tyrosine by tyrosine hydroxylase [12]. Therefore, to know the treatment and study of the mechanism of Parkinson’s disease simultaneous determination of levodopa and tyrosine in human plasma can be of analytical interest [13]. Various analytical techniques for simultaneous determination of levodopa, tyrosine and related compounds in different biological matrices, including plasma and urine have been reported in literature\nsuch as high-performance liquid chromatography [14], spectrophotometry [15], chemiluminiscence [16], capillary electrophoresis [17] and NMR detection [18]. These methods are time consuming and/or expensive and often need the pretreatment step. Also, some of them suffer from low sensitivity and selectivity in the corresponding determinations [19], but electrochemical methods present distinctive advantages, such as quick response, low detection limit, low cost, simple operation and the absence of pretreatment [20].\nThe screen-printed electrodes (SPEs) have been designed especially for miniaturization of electrochemical analytical systems [21,22]. SPEs are highly-versatile, easy to use, cost-effective analytical tools, also suitable to miniaturization [23,24]. Furthermore, a screen printed electrode avoids the cleaning process, unlike conventional electrodes such as a glassy carbon electrode (GCE) [25].\n[a] H. Beitollahi Environment Department Institute of Science and High Technology and Environmental Sciences Graduate University of Advanced Technology, Kerman, Iran Tel.: +983426226613 Fax: +983426226617 *e-mail: h.beitollahi@yahoo.com\n[b] F. Garkani Nejad Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/elan.201600143.\nnano sensor has excellent performance such as high sensitivity, good selectivity and analytical application in real samples. The combination of graphene oxide/ZnO nanorods nano composite with the screen-printed electrode is favorable for amplifying electrochemical signals. Under optimized conditions square wave voltammetry (SWV) exhibited linear dynamic ranges from 1.0 10 6 to 1.0 10 3 M and 1.0 10 6 to 8.0 10 4 M with detection limits of 4.5 10 7 M and 3.4 10 7 M for levodopa and tyrosine respectively.\nKeywords: Levodopa · Tyrosine · Graphene oxide/ZnO nanorods · Screen-printed electrodes\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &1&\nThese are not the final page numbers!\nIn order to improve their electrochemical performance, SPEs have been modified with nano sized materials [26,27].\nThe modified electrode has good electro catalytic activity, sensitivity, and selectivity; it has also a low detection limit compared to unmodified electrodes [28–32]. Nanostructures modified electrodes have been adopted as a promising way to facilitate the direct electron transfer of biomolecules [33–39]. These nanostructures include, for example, carbon nanomaterials, Au nanoparticles, and nanostructures metal oxides. Among metal oxides, ZnO nanostructures due to wide band gap (3.37 eV), large excitation binding energy (60 eV), non-toxicity, and high electron communication features is preferred for the fabrication of efficient sensors [40,41].\nGraphene, as a novel one-atom thick planar sheet of sp2 hybridized carbon atoms packed in a honeycomb lattice, has attracted considerable attention in recent years due to its high mobility of charge carriers, high specific surface area and outstanding electrical conductivity [42– 56]. Therefore, graphene based composites for example, graphene/ZnO can be deeply investigated as novel electrode modification materials for the improvement of sensing sensitivity.\nTo the best of our knowledge, no study has been reported so far on the simultaneous determination of levodopa and tyrosine by using graphene oxide/ZnO nanorods (GR/ZnO) nano composite-screen printed electrodes (GR/ZnO/SPE). In this study, we report the preparation and application of a modified graphene oxide/ZnO nanorods (GR/ZnO) nano composite-screen printed electrode for the simultaneous determination of levodopa and tyrosine without any additional modification such as addition of electron transfer mediator or specific reagents for the first time. The main objectives of this graphene oxide/ ZnO nanorods (GR/ZnO) nano composite-screen printed electrodes for simultaneous determination of levodopa and tyrosine are: wide linear dynamic range, short time of the procedure and no use of electron transfer mediator. Although, some chromatographic and biosensing methods show better LOD than that of the developed method, but these methods suffer from extensive and expensive pre-treatment steps and lengthy time of analysis."
    }, {
      "heading" : "2 Experimental",
      "text" : ""
    }, {
      "heading" : "2.1 Apparatus and Chemicals",
      "text" : "The electrochemical measurements were performed with an Autolab potentiostat/galvanostat (PGSTAT 302N, Eco Chemie, the Netherlands). The experimental conditions were controlled with General Purpose Electrochemical System (GPES) software. Graphite screen printed electrodes were purchased from Italsens Co. A Metrohm 710 pH meter was used for pH measurements.\nLevodopa, tyrosine and all of the other reagents were of analytical grade and were obtained from Merck (Darmstadt, Germany). The buffer solutions were pre-\npared from orthophosphoric acid and its salts in the pH range of 2.0–9.0."
    }, {
      "heading" : "2.2 Synthesis of Graphene Oxide/ZnO Nanorods Nano Composite",
      "text" : "Graphene oxide nano sheets were synthesized from natural graphite flakes based on the modified Hummers and Offeman s method. The reduced graphene oxide (0.096 g) was dispersed in 40 ml water and the solution was kept in ultrasonic bath for 1 h. The prepared solution was added to 40 ml of ZnCl2 (0.04 M) solution. Final solution pH was set 11.7 by ammonia solution. The solution was kept at 95 8C for 4 h. The precipitate was gathered at 15000 rpm centrifugation for 15 min. Then it was washed by distilled water three times. Finally it was dried in oven at 45 8C for 4 h."
    }, {
      "heading" : "2.3 Preparation of the Electrode",
      "text" : "The bare screen-printed electrode was coated with GR/ ZnO as follows. A stock solution of GR/ZnO in 1 mL aqueous solution was prepared by dispersing 1 mg GR/ ZnO with ultrasonication for 1 h, and a 2 ml aliquot of the GR/ZnO/H2O suspension solution was casted on the carbon working electrodes, waiting until the solvent was evaporated in room temperature."
    }, {
      "heading" : "2.4 Preparation of Real Samples",
      "text" : "Urine samples were stored in a refrigerator immediately after collection. Ten milliliters of the sample was centrifuged for 15 min at 2000 rpm. The supernatant was filtered out using a 0.45 mm filter. Then, different volume of the solution was transferred into a 25 mL volumetric flask and diluted to the mark with PBS (pH 7.0). The diluted urine sample was spiked with different amounts of levodopa and tyrosine. The levodopa and tyrosine contents were analyzed by the proposed method using the standard addition method.\nThe serum sample was centrifuged and after filtering, diluted with PBS (pH 7.0) without any further treatment. The diluted serum sample was spiked with different amounts of levodopa and tyrosine. The levodopa and tyrosine contents were analyzed by the proposed method using the standard addition method."
    }, {
      "heading" : "3 Results and Discussion",
      "text" : ""
    }, {
      "heading" : "3.1 SEM Characterization",
      "text" : "A comparison of the surface morphology of unmodified SPE and GR/ZnO /SPE was studied by recording SEM images as shown in Fig. 1. It can be seen that on the surface of SPE (Fig. 1A), the layer of irregular flakes of graphite powder were presented and isolated from each other. After GR/ZnO were added to the SPE, it can be seen that GR/ZnO were distributed on the electrode with\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &2&\nThese are not the final page numbers!\nspecial three-dimensional structure (Fig. 1B), indicating that the GR/ZnO successfully modified the surface of SPE."
    }, {
      "heading" : "3.2 Electrochemical Behavior of Levodopa and Tyrosine at the Surface of Various Electrodes",
      "text" : "The electrochemical behaviors of levodopa and tyrosine are dependent on the pH value of the aqueous solution. Therefore, pH optimization of the solution seems to be necessary in order to obtain the best results for electrooxidation of levodopa and tyrosine. Thus the electrochemical behaviors of levodopa and tyrosine were studied in 0.1 M PBS in different pH values (2.0–9.0) at the surface of GR/ZnO/SPE by voltammetry. It was found that the electro-oxidation of levodopa and tyrosine at the surface of GR/ZnO/SPE was more favored under neutral conditions than in acidic or basic medium. Thus, the pH 7.0 was chosen as the optimum pH for electro-oxidation of levodopa and tyrosine at the surface of GR/ZnO/ SPE.\nFig. 2 depicts the CV responses for the electro-oxidation of 400.0 mM levodopa (Fig. 2A) and 400.0 mM tyrosine (Fig. 2B) at an unmodified SPE (curve a) and GR/ ZnO/SPE (curve b). The peak potential due to the oxidation of levodopa occurs at 370 mV, which is about 130 mV more negative than that of unmodified SPE.\nAlso, the peak potential due to the oxidation of tyrosine occurs at 750 mV, which is about 60 mV more negative than that of unmodified SPE. Also, GR/ZnO/SPE shows much higher anodic peak current for the oxidation of levodopa and tyrosine compared to unmodified SPE, indicating that the modification of unmodified SPE with GR/ ZnO nanocomposite has significantly improved the performance of the electrode toward levodopa and tyrosine oxidation."
    }, {
      "heading" : "3.3 Effect of Scan Rate",
      "text" : "The effect of potential scan rates on the oxidation current of levodopa (Fig. 3) and tyrosine (Fig. 4) have been studied. The results showed that increasing in the potential scan rate induced an increase in the peak current. In addition, the oxidation processes are diffusion controlled as deduced from the linear dependence of the anodic peak current (Ip) on the square root of the potential scan rate (n1/2) for both of analytes.\nTafel plots were drawn from data of the rising part of the current voltage curves recorded at a scan rate of 10 mVs 1 for levodopa (Fig. 3B) and tyrosine (Fig. 4B). These parts of voltammogram, known as Tafel region, are affected by electron transfer kinetics between substrate (levodopa or tyrosine) and GR/ZnO/SPE. Tafel slopes of 0.087 V and 0.117 V were obtained which agree well with\nFig. 1. SEM image of (A) unmodified SPE and (B) GR/ZnO/SPE.\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &3&\nThese are not the final page numbers!\nthe involvement of one electron in the rate determining step of the electrode process [57] assuming charge transfer coefficients, a=0.33 and a=0.44 for levodopa and tyrosine respectively."
    }, {
      "heading" : "3.4 Chronoamperometric Measurements",
      "text" : "Chronoamperometric measurements of levodopa and tyrosine at GR/ZnO/SPE were carried out by setting the working electrode potential at 0.5 V and 0.85 V vs. Ag/ AgCl/KCl (3.0 M) for the various concentrations of levodopa (Fig. 1S) and tyrosine (Fig. 2S) in PBS (pH 7.0) respectively. For electroactive materials (levodopa or tyrosine in this case) with a diffusion coefficient of D, the current observed for the electrochemical reaction at the\nmass transport limited condition is described by the Cottrell equation [57]:\nI ¼ nFAD1=2Cbp 1=2t 1=2 ð1Þ\nWhere D and Cb are the diffusion coefficient (cm 2 s 1) and the bulk concentration (mol cm 3), respectively. Experimental plots of I vs. t 1/2 were employed, with the best fits for different concentrations of levodopa (Fig. 1SA) and tyrosine (Fig. 2SA). The slopes of the resulting straight lines were then plotted vs. levodopa (Fig. 1SB) and tyrosine (Fig. 2SB) concentrations. From the resulting slopes and Cottrell equation the mean values of the D were found to be 1.1 10 6 cm2/s and 1.6 10 6 cm2/s for levodopa and tyrosine respectively."
    }, {
      "heading" : "3.5 Calibration Plots and Limits of Detection",
      "text" : "The electro-oxidation peak currents of levodopa and tyrosine at the surface of the GR/ZnO/SPE can be used for determination of levodopa and tyrosine in solution. Since, square wave voltammetry (SWV) has the advantage of an increase in sensitivity and better characteristics for analytical applications, therefore, SWV experiments were performed using GR/ZnO/SPE in 0.1 M PBS containing various individual concentrations of levodopa (Fig. 3S) and tyrosine (Fig. 4S). The results show the electrocatalytic peak currents of levodopa oxidation at the surface of GR/ZnO/SPE were linearly dependent on the levodopa concentrations, over the range of 1.0 10 6–1.0 10 3 M (with a correlation coefficient of 0.9987) and the detection limit (3s) was obtained 4.5 10 7 M.\nIn the case of tyrosine electro-oxidation peak currents of tyrosine at the surface of GR/ZnO/SPE were linearly dependent on the tyrosine concentrations, over the range of 1.0 10 6–8.0 10 4 M (with a correlation coefficient of 0.9991) and the detection limit (3s) was obtained 3.4 10 7 M."
    }, {
      "heading" : "3.6 Simultaneous Determination of Levodopa and Tyrosine",
      "text" : "To our knowledge, no paper has used the GR/ZnO/SPE for simultaneous determination of levodopa and tyrosine and this is the first report for simultaneous determination of levodopa and tyrosine using GR/ZnO/SPE. The electrochemical determination of levodopa using bare electrodes suffers from interference by tyrosine, because the oxidation potential for tyrosine is fairly close to that of levodopa. The determination of two compounds was performed by simultaneously changing the concentrations of levodopa and tyrosine, and recording the SWVs (Fig. 5). The voltammetric results showed well-defined anodic peaks at potentials of 300 and 650 mV, corresponding to the oxidation of levodopa and tyrosine, respectively, indicating that simultaneous determination of these compounds is feasible at the GR/ZnO/SPE as shown in Fig. 5.\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &4&\nThese are not the final page numbers!"
    }, {
      "heading" : "3.7 Interferences Study",
      "text" : "The influence of various substances as compounds potentially interfering with the determination of levodopa and tyrosine were studied under optimum conditions with 50.0 mM levodopa and 50.0 mM tyrosine at pH 7.0. The potentially interfering substances were chosen from the group of substances commonly found with levodopa and tyrosine in pharmaceuticals and/or in biological fluids. The tolerance limit was defined as the maximum concentration of the interfering substance that caused an error of less than 5 % in the determination of levodopa or tyrosine. According to the results, glucose, sucrose, lactose, fructose, citric acid, methanol, ethanol, Mg2+, SO4\n2 , Al3+, NH4 +, Fe2+ , Fe3+ , CO3 2 , Cl or F , alanine, methio-\nnine, phenylalanine, glycine, folic acid (vitamin B9), saturated starch solution and urea did not interfere with the determination of levodopa and tyrosine. But dopamine, ascorbic acid, epinephrine and norepinephrine with equal molar showed interference in determination of levodopa and tyrosine. Although ascorbic acid showed interference, this interference could be minimized, if necessary, by using ascorbic oxidase enzyme, which exhibits a high selectivity to the oxidation of ascorbic acid."
    }, {
      "heading" : "3.8 Real Sample Analysis",
      "text" : "In order to evaluate the analytical applicability of the proposed method, also it was applied to the determination of levodopa and tyrosine in human blood serum and\nFig. 3. CVs of GR/ZnO/SPE in 0.1 M PBS (pH 7.0) containing 1000.0 mM levodopa at various scan rates; numbers 1–11 correspond to 10, 20, 30, 50, 70, 100, 200, 400, 600, 800 and 1000 mVs 1, respectively. Insets (A) Variation of anodic peak current vs. square root of scan rate and (B) Tafel plot derived from the CV at the scan rate of 10 mV s 1.\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &5&\nThese are not the final page numbers!\nurine samples using a standard addition method. The results for determination of the two species in real samples are given in Table 1. Satisfactory recoveries of the experimental results were found for levodopa and tyrosine. The reproducibility of the method was demonstrated by the mean relative standard deviation (R.S.D.)."
    }, {
      "heading" : "4 Conclusions",
      "text" : "In this work, employing graphene oxide/ZnO nanorods nano composite as modifier in modification of SPEs, a novel sensor has been developed that provides an extremely sensitive and selective method for the simultaneous determination of levodopa and tyrosine. The proposed protocol demonstrated herein a novel, simple, portable, inexpensive and easy-to-use fabrication method for the measurement of levodopa and tyrosine concentrations in human blood serum and urine samples with good analytical performance. Due to the unique properties of graphene oxide/ZnO nanorods nano composite, the sensor exhibited remarkable electrochemical activity toward the oxidation of levodopa and tyrosine and also resolved the overlapping anodic peak responses of levodopa and tyrosine into two well-defined peaks.\nFig. 4. CVs of GR/ZnO/SPE in 0.1 M PBS (pH 7.0) containing 500.0 mM tyrosine at various scan rates; numbers 1–11 correspond to 10, 20, 30, 50, 70, 100, 200, 400, 600, 800 and 1000 mV s 1, respectively. Insets (A) Variation of anodic peak current vs. square root of scan rate and (B) Tafel plot derived from the CV at the scan rate of 10 mVs 1.\nwww.electroanalysis.wiley-vch.de 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Electroanalysis 2016, 28, 1 – 9 &6&\nThese are not the final page numbers!\nFig. 5. SWVs obtained at the surface of GR/ZnO/SPE in 0.1 M PBS (pH 7.0) containing different concentrations of levodopa and tyrosine. SWVs from inner to outer correspond to 1.0+10.0, 15.0+50.0, 30.0+75.0, 60.0+100.0, 200.0+200.0, 350.0+300.0, 600.0+ 500.0 and 900.0+750.0 mM levodopa and tyrosine respectively. Insets (A) plots of Ip vs. levodopa concentrations and (B) plot of Ip vs. tyrosine concentrations."
    } ],
    "references" : [ {
      "title" : "Namadchian, Electrochim",
      "author" : [ "M.M. Baghayeri" ],
      "venue" : "Acta 2013,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2013
    }, {
      "title" : "Electrochemical Methods: Fundamentals and Applications",
      "author" : [ "A.J. Bard", "L.R. Faulkner" ],
      "venue" : "second ed., Wiley, New York, NY",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2001
    } ],
    "referenceMentions" : [ {
      "referenceID" : 1,
      "context" : "the involvement of one electron in the rate determining step of the electrode process [57] assuming charge trans-",
      "startOffset" : 86,
      "endOffset" : 90
    } ],
    "year" : 2016,
    "abstractText" : "Parkinson s disease is a chronic neurodegenerative disease that occurs when the substantia nigra of the midbrain dies and fails to generate enough dopamine [1]. This condition causes tremors, muscle stiffness or rigidity, slowness of movement and poor balance [2]. Levodopa, is one of the catecholamine and a kind of the essential precursors for the biosynthesis of dopamine. Levodopa can be principally metabolized by an enzymatic reaction (dopa-descarboxilase) to dopamine compensating for the deficiency of dopamine in the brain [3]. Introduction of levodopa in the 1960s revolutionized the treatment of Parkinson s disease [4]. Dopamine cannot be administered directly because it cannot penetrate the blood brain barrier, but since levodopa is able to cross the bloodbrain barrier, it is used to increase dopamine levels [5–7]. Tyrosine is an important amino acid that extensively exists in human body [8, 9]. In the human body, tyrosine is a precursor of several neurotransmitters including levodpa, norepinephrine and epinephrine [10,11] and levodopa is synthesized from tyrosine by tyrosine hydroxylase [12]. Therefore, to know the treatment and study of the mechanism of Parkinson’s disease simultaneous determination of levodopa and tyrosine in human plasma can be of analytical interest [13]. Various analytical techniques for simultaneous determination of levodopa, tyrosine and related compounds in different biological matrices, including plasma and urine have been reported in literature such as high-performance liquid chromatography [14], spectrophotometry [15], chemiluminiscence [16], capillary electrophoresis [17] and NMR detection [18]. These methods are time consuming and/or expensive and often need the pretreatment step. Also, some of them suffer from low sensitivity and selectivity in the corresponding determinations [19], but electrochemical methods present distinctive advantages, such as quick response, low detection limit, low cost, simple operation and the absence of pretreatment [20]. The screen-printed electrodes (SPEs) have been designed especially for miniaturization of electrochemical analytical systems [21,22]. SPEs are highly-versatile, easy to use, cost-effective analytical tools, also suitable to miniaturization [23,24]. Furthermore, a screen printed electrode avoids the cleaning process, unlike conventional electrodes such as a glassy carbon electrode (GCE) [25].",
    "creator" : "Arbortext Advanced Print Publisher 9.1.580/W"
  }
}